May 2019 newsletter
Release of PickR™ V1.0 enables selection of electrostatically diverse monomers for high quality libraries and better intellectual property Unlike existing ...
Hot targets in drug discovery are constantly changing, paradigm shifts are a bit rarer. Protein degradation is an exciting new example of the latter. Martin Slater describes how Cresset Discovery Services tackles therapeutic protein degradation by design.
Thank you to all attendees who contributed to the success of the Cresset User Group Meeting 2019. See the presentations we have permission to publish. We hope to see you at the Cresset User Group Meeting 2020 on 18-19 June in Cambridge, UK.
Merck Research Laboratories, Boston, was the host for this meeting with a central theme 'Design, Make, Test and Analysis', effecting efficient collaboration, and information sharing across all processes involved with drug discovery, design and synthesis (Design-Make-Test- Analysis, DMTA). Rachelle Bienstock reviews the presentations.
The intuitive navigation of the new Cresset website presents our software and services offering in a clear structure, helping computational chemists, medicinal chemists, biologists and academics find the right solutions to progress their project.